1460776117-246a7ced-2e43-4519-af1c-4b647415e9a0

What is claimed is:

1. An isolated or purified T-lymphocyte derived from abdominal aortic tissue, the T-lymphocyte is specifically reactive with collagen I or collagen III or fragment thereof.
2. A method of preventing or treating an abdominal aortic aneurysm or rupture in a mammal comprising administering to the mammal an effective amount of an immunosuppressive agent that inhibits T-lymphocyte reactivity with collagen I or collagen III or epitope thereof, thereby preventing or treating the abdominal aortic aneurysm or rupture.
3. A method according to claim 2, wherein the immunosuppressive agent is selected from the group such as azathioprine, cyclosporine, methotrexate, prednisone, methylprednisolone, prednisolone, hydrocortisone, cortisone and combinations thereof.
4. A vaccine for preventing an abdominal aortic aneurysm or rupture in a mammal comprising an effective amount of collagen or epitope thereof isolated from abdominal aortic aneurysm tissue, the collagen capable of producing an immune response in a mammal.
5. A vaccine according to claim 4, wherein the immune response is production of antibodies specifically reactive with collagen I, or collagen III or epitope thereof.
6. A vaccine according to claim 4, wherein the immune response is the production of cytokines.
7. A monoclonal antibody that specifically reacts with an epitope of collagen I, or collagen III, the epitope isolated from abdominal aortic aneurysm tissue.
8. A kit for determining an individual’s risk for developing and abdominal aortic aneurysm andor rupture of AAA, comprising a container and a monoclonal antibody that specifically reacts with collagen I, collagen III, or epitope thereof, wherein the collagen I, collagen III or epitope thereof is synthesized or isolated from abdominal aortic aneurysm tissue.
9. A method of stimulating or inhibiting an immune response in a mammal to prevent or treat an abdominal aortic aneurysm or rupture comprising administering to the mammal an effective amount of collagen I, collagen III, epitope thereof or combination thereof so as to produce antibodies that inhibit T-lymphocyte reactivity with collagen I, collagen III or combination thereof, thereby stimulating the immune response to prevent or treat the abdominal aortic aneurysm or rupture.
10. A method of stimulating or inhibiting an immune response in a mammal to prevent or treat an abdominal aortic aneurysm comprising administering to the mammal and effective amount of collagen I, collagen III, epitope thereof or combinations thereof so as to bind T-lymphocytes, thereby preventing or treating the abdominal aortic aneurysm or rupture.
11. A method for determining a mammal’s risk for developing an abdominal aortic aneurysm or rupture comprising
(a) obtaining a sample of aortic tissue from the mammal;
(b) incubating the sample with one or more T-lymphocytes under suitable conditions so as to react the T-lymphocytes with collagen I, collagen III, epitope thereof or combination thereof, and
(c) determining the reactivity of the T-lymphocytes with collagen I, collagen III, or epitope thereof or combination thereof by measuring cytokine release from the T lymphocytes derived from AAA tissue, wherein cytokine release or other T lymphocyte response indicates increased risk of developing an abdominal aortic aneurysm or rupture.
12. A pharmaceutical composition comprising an effective amount of an epitope of collagen I, collagen III, or epitope thereof, wherein the epitope is isolated from abdominal aortic aneurysm tissue and is specifically reactive with T-lymphocytes.
13. A method of detecting collagen I, collagen III, epitope, or combination thereof comprising:
(a) obtaining a sample of aortic tissue;
(b) incubating the sample with one or more T-lymphocytes under suitable conditions so as to react the T-lymphocytes with collagen I, collagen III, epitope or combination thereof and (c) detecting collagen I, collagen III, epitope thereof or combination thereof by measuring proliferation, cytokine release or other reactivity of T-lymphocytes, wherein the response of the T-lymphocytes indicates the presence of collagen I, collagen III, epitope thereof, or combination thereof.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A chemical composition for use in drilling operations for oil recovery, the chemical composition comprising:
an ammonia compound,
an alcohol; and
an aqueous carrier solution, the aqueous carrier solution being of sufficient volume operable to fully dissolve the ammonia compound and alcohol in the aqueous carrier solution, the ammonia compound and the alcohol being substantially distributed throughout the carrier fluid.
2. The chemical composition of claim 1 wherein the alcohol contains from about one to about six carbon atoms and is non-aromatic.
3. The chemical composition of claim 2 wherein the alcohol is propyl alcohol.
4. The chemical composition of claim 3 wherein the alcohol is isopropyl alcohol.
5. The chemical composition of claim 2 wherein the alcohol is butyl alcohol.
6. The chemical composition of claim 2 wherein the alcohol is ethyl alcohol.
7. The chemical composition of claim 2 wherein the alcohol is methyl alcohol.
8. The chemical composition of claim 1 wherein the carrier solution is water.
9. The chemical composition of claim 1 wherein the carrier solution consists essentially of water.
10. The chemical composition of claim 1 wherein the ammonia compound is ammonia.
11. The chemical composition of claim 1 wherein the ammonia compound is ammonium hydroxide.
12. The chemical composition of claim 1 wherein the alcohol is in an amount of approximately 4 to 16 percent by volume of the chemical composition.
13. The chemical composition of claim 1 wherein the ammonia compound is in an amount of approximately 2 to 8 percent by volume of the chemical composition.
14. The chemical composition of claim 1 wherein the carrier solution is in an amount of approximately 76 to 94 percent by volume of the chemical composition.
15. The chemical composition of claim 1 wherein the alcohol and the ammonia compound define a ratio of alcohol to ammonia compound, the ratio being between approximately 1:1 alcohol to ammonia and approximately 3:1 alcohol to ammonia, the ratio being on a volume basis.
16. A process for recovering hydrocarbons from a hydrocarbon formation containing hydrocarbon reserves, the process comprising the steps of:
introducing the chemical composition of claim 1 into the hydrocarbon formation in an amount effective to, when added to the formation, substantially increase the recovery of hydrocarbons from the reserve; and
recovering hydrocarbons from the hydrocarbon formation.
17. The process for recovering hydrocarbons of claim 16 further comprising the step of recovering a significant amount of the chemical composition subsequent to the introduction of the chemical composition into the hydrocarbon formation such that the chemical composition can be used again in the hydrocarbon formation.